Genprex, Inc. (GNPX) vs Jupiter Neurosciences, Inc. (JUNS)

A side-by-side comparison of Genprex, Inc. and Jupiter Neurosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Genprex, Inc. logo
GNPX
Genprex, Inc.
$1M
$2.71HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
Jupiter Neurosciences, Inc. logo
JUNS
Jupiter Neurosciences, Inc.
$1M
$2.50HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT

Total return — GNPX vs JUNS

growth of $100 · dividends reinvested · last 2y
GNPX -99.8% (-95.3%/yr)JUNS -99.4% (-92.3%/yr)JUNS compounded faster over this window
0100200300Start $10020252026$0$1
GNPX JUNS

GNPX vs JUNS: by the numbers

  • •GNPX is the larger company ($1M vs $1M market cap).
  • •Both run net losses; GNPX's is the smaller (0.00% vs -14220.12% net margin).

Metrics side by side

Valuation

MetricGNPXJUNS
P/S ratioN/A18.73
P/B ratio0.09N/A

Profitability

MetricGNPXJUNS
Gross margin0.00%88.34%
Operating margin0.00%-40873.19%
Net margin0.00%-14220.12%
ROE-111.51%N/A
ROIC-107.08%-709.40%

Growth (annualized)

MetricGNPXJUNS
Revenue CAGR (5Y)N/A-47.77%
Total return CAGR (5Y)-88.16%N/A

Go deeper

Full GNPX analysisFull JUNS analysisInteractive comparison tool

Dig into the metrics

Genprex ROEJupiter Neurosciences ROEGenprex operating marginJupiter Neurosciences operating marginGenprex revenue growthJupiter Neurosciences revenue growthGenprex free cash flowJupiter Neurosciences free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.